Well, better late than never is a good way to put it, Lisa, because the news is pretty good on a two month basis. Remember, we didn't get October CPI and we're not going to get much out of that 2.7% for the year over year move in CPI. That is down from 3% in September.The last release we got the core CPI on a year over year basis falls from 3% to 2.6%. So good news on inflation. Meanwhile, good news on the job front with initial jobless claims falling to 224,000 from 237,000 revised the week prior.On a cont ...

It has not been a smooth ride for natural gas liquefier NextDecade Corporation ( NEXT ), whose shares have declined 24.22% year-over-year (YoY) and 33.46% year-to-date (YTD). However, what caught my eye is that the company has been growing its cash reserves atI have more than five years experience in the financial industry. I focus mostly in the commodities, foreign exchange and cryptocurrencies. I also write on general issues like equity research, economics and geopolitics.Fellow contributor Crispus Nyaga ...

Darden Restaurants (DRI) came out with quarterly earnings of $2.08 per share, missing the Zacks Consensus Estimate of $2.09 per share. This compares to earnings of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.48%. A quarter ago, it was expected that this owner of Olive Garden and other chain restaurants would post earnings of $2 per share when it actually produced earnings of $1.97, delivering a surprise of -1.5%.O ...

FactSet Research (FDS) came out with quarterly earnings of $4.51 per share, beating the Zacks Consensus Estimate of $4.39 per share. This compares to earnings of $4.37 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.73%. A quarter ago, it was expected that this financial data firm would post earnings of $4.15 per share when it actually produced earnings of $4.05, delivering a surprise of -2.41%.Over the last four quarters, ...

Core Viewpoint - Warner Bros. is advocating for shareholders to reject a hostile takeover bid from Paramount Skydance in favor of a $72 billion buyout offer from Netflix, which it considers superior [1][5]. Group 1: Offers and Valuations - Paramount's offer is $30 per share, valuing Warner Bros. at approximately $77.9 billion, while Netflix's offer is $27.75 per share, valuing Warner at $72 billion [1][5][6]. - Paramount's bid includes a cash component and aims to acquire Warner's cable assets, which Netflix's offer does not include [5][6]. - Paramount claims its offer is about $18 billion more in cash than Netflix's bid [5]. Group 2: Regulatory Scrutiny - Both offers are expected to face intense scrutiny from U.S. regulators due to their potential impact on the entertainment landscape, including movie production and consumer streaming platforms [2][3][13]. - Concerns regarding the Netflix offer center around the size of the combined subscription service, as Netflix is already the largest streaming service globally [13][14]. - The Paramount deal may raise regulatory concerns regarding the consolidation of film and television studios, given the limited number of such entities remaining in the market [14]. Group 3: Market Dynamics - The competition between Netflix and Paramount for Warner Bros. highlights the ongoing consolidation trend in the media industry, as companies seek growth through acquisitions [15][16]. - The involvement of high-profile investors, including Jared Kushner and funds from Saudi Arabia and Qatar, adds complexity to the Paramount bid [6][12]. - Analysts suggest that the presence of competing offers increases the likelihood of Warner Bros. being acquired, as it shifts the decision-making landscape [9].

If you've been waiting for an opportunity to pick up shares of Microsoft (NASDAQ:MSFT) on the cheap amid broad AI and tech jitters, here's your chance. ...

ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. ("AV†) (NASDAQ: AVAV), a leading provider of counter-unmanned aircraft system (C-UAS) technologies, today announced the successful delivery of two Joint Light Tactical Vehicle (JLTV)-mounted mobile C-UAS Laser Weapon Systems (LWS) to the U.S. Army as part of the second increment of the Army Multi-Purpose High Energy Laser (AMP-HEL) prototyping effort. These systems were delivered to the Army's Rapid Capabilities and Critical Technologies Office (RCCTO), ...

Nanchang, China, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Ruanyun Edai Technology Inc. (“Ruanyun” or the “Company”) (Nasdaq: RYET), an education-focused artificial intelligence company delivering AI-enabled learning, assessment, and digital education solutions globally, today announced that it has entered into a $100 million equity purchase facility with ARC Group International Ltd. (“ARC”), a global investment bank. Under the terms of the agreement, the Company has the right, but not the obligation, to sell ordin ...

Back in September, I termed Oracle 's ( ORCL ) breathtaking pop into the $300s an "overshoot" while issuing a "Hold/Neutral/Avoid" rating on the technology giant, citing two significant risk factors associated with its aggressive push to become the 4th cloud hyperscaler and ORCL's stock overvaluation:"We're in an asset bubble, and TQI can help you navigate it profitably"I am Ahan Vashi, a seasoned investor with professional background in equity research, private equity, and software engineering. I currently ...

Core Viewpoint - Novo Nordisk has filed for U.S. FDA approval of CagriSema, a once-weekly injection designed to treat obesity by combining two compounds [1] Company Summary - CagriSema represents a new treatment option in the obesity market, potentially expanding Novo Nordisk's portfolio in this growing sector [1] Industry Summary - The obesity treatment market is experiencing significant growth, and the introduction of CagriSema could enhance competition among pharmaceutical companies [1]